Statin therapy in autoimmunity: From protein prenylation to immunomodulation
By J. Greenwood, L. Steinman, S. Zamvil. Nature reviews. Immunology, 2006
679 citations recorded by the source corpus.
Statins have been prescribed extensively for their cholesterol-lowering properties and efficacy in cardiovascular disease. However, compelling evidence now exists that statins also have extensive immunomodulatory properties that operate independently of lipid lowering. Consequently, much attention has been directed towards their potential as therapeutic agents for the treatment of autoimmune disease. Modulation of post-translational protein prenylation seems to be a key mechanism by which statins alter immune function. In this Review, the effect of statin therapy on immune function, and how this relates to the pathogenesis of autoimmune disease, is reviewed alongside current opinion of what the key biological targets of statins are.
Subfields: Immunology, Radiology, Nuclear Medicine and Imaging, Rheumatology
View Paper: https://www.semanticscholar.org/paper/6ecbb3fb211e2cba86d1f328dbaa111cfcbd06fa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. (2008, background): “Indeed, recent studies suggest that statins might be involved in immunomodulation [10], neuroprotection [11] and cellular senescence [12].”